DE VITO, FRANCESCA
 Distribuzione geografica
Continente #
AS - Asia 298
EU - Europa 272
NA - Nord America 255
AF - Africa 1
SA - Sud America 1
Totale 827
Nazione #
US - Stati Uniti d'America 242
SG - Singapore 176
DE - Germania 143
HK - Hong Kong 108
IT - Italia 74
CA - Canada 13
GB - Regno Unito 11
PK - Pakistan 9
EE - Estonia 7
FI - Finlandia 7
LT - Lituania 7
RU - Federazione Russa 6
NL - Olanda 5
BD - Bangladesh 4
BE - Belgio 3
ES - Italia 3
AT - Austria 2
BR - Brasile 1
CH - Svizzera 1
PL - Polonia 1
RO - Romania 1
SE - Svezia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 827
Città #
Hong Kong 108
Falkenstein 96
Singapore 87
Chicago 47
Rome 47
Frankfurt am Main 31
West Jordan 24
Boardman 15
Santa Clara 15
Buffalo 11
Elk Grove Village 8
Toronto 8
Helsinki 7
London 7
Moscow 6
Naples 6
Charlotte 5
Los Angeles 5
Ottawa 5
Ashburn 4
Bologna 4
Brussels 3
Galbiate 3
San Francisco 3
The Dalles 3
Ettlingen 2
New York 2
Nuremberg 2
Raviscanina 2
Zona Industriale 2
Amsterdam 1
Atlanta 1
Brooklyn 1
Carney 1
Grellingen 1
Las Vegas 1
Phoenix 1
Secaucus 1
Stockholm 1
São Paulo 1
Totale 578
Nome #
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 39
Dopaminergic dysfunction is associated with IL-1??-dependent mood alterations in experimental autoimmune encephalomyelitis 35
Interaction between interleukin-1?? and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 35
Acute Stress Alters Amygdala microRNA miR-135a and miR-124 Expression: Inferences for Corticosteroid Dependent Stress Response 34
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 26
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 25
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 25
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 25
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 25
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 24
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 24
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 23
RNA-binding protein HuR and the members of the miR-200 family play an unconventional role in the regulation of c-Jun mRNA 23
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 23
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 23
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 22
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment 22
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 21
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis. 21
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 18
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 18
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 18
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 18
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 18
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 18
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 18
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 17
miR-142-3p Is a Key Regulator of IL-1??-Dependent Synaptopathy in Neuroinflammation 17
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 16
Interleukin-1 Alters Glutamate Transmission at Purkinje Cell Synapses in a Mouse Model of Multiple Sclerosis 16
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 16
Cyclin D1 is a major target of miR-206 in cell differentiation and transformation 16
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 16
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 16
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 15
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 15
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 14
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 14
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis 14
Stress induces region specific alterations in microRNAs expression in mice 13
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 13
miR-135a Regulates Synaptic Transmission and Anxiety-Like Behavior in Amygdala 13
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 12
microRNAs Modulate Spatial Memory in the Hippocampus and in the Ventral Striatum in a Region-Specific Manner 12
Totale 886
Categoria #
all - tutte 6.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.685


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202471 0 0 0 0 0 0 16 0 0 48 0 7
2024/2025815 11 24 6 75 87 46 171 172 45 39 115 24
Totale 886